US Stock Futures Drop Ahead Of Economic Data

Loading...
Loading...
Pre-open movers
US stock futures traded lower in early pre-market trade. Data on motor vehicle sales for October will be released today. The Markit PMI manufacturing index for October will be released at 9:45 a.m. ET, while the ISM manufacturing composite index for October and construction spending data for September will be released at 10:00 a.m. ET. Futures for the Dow Jones Industrial Average tumbled 25 points to 17,286.00, while the Standard & Poor's 500 index futures fell 2.10 points to 2,009.30. Futures for the Nasdaq 100 index dropped 3.75 points to 4,146.75.
A Peek Into Global Markets
European markets were lower today, with the Spanish Ibex Index falling 0.58%, STOXX Europe 600 Index dropping 0.27%. German DAX 30 index slipped 0.37%, French CAC 40 Index declined 0.37% and London's FTSE 100 Index dropped 0.33%. Eurozone manufacturing PMI climbed to 50.6 in October, versus 50.3 in September. In Asian markets, Hong Kong's Hang Seng Index fell 0.34%, China's Shanghai Composite Index jumped 0.41% and India's Sensex fell 0.02%. The HSBC China Manufacturing PMI surged to a final reading of 50.4 in October, versus 50.2 in September.
Broker Recommendation
Analysts at Pacific Crest upgraded NVIDIA
NVDA
from Underperform to Sector Perform. NVIDIA's shares rose 4.55% to close at $19.54 on Friday.
Breaking news
  • Sally Beauty Holdings SBH today announced the retirement of Martha J. Miller from the Board of Directors (the “Board”) of Sally Beauty Holdings, Inc., effective November 3, 2014. To read the full news, click here.
  • SAGE Therapeutics SAGE today announced that SAGE-547, an allosteric modulator of GABA[A] receptors, was used to treat super-refractory status epilepticus (SRSE) in two pediatric patients. To read the full news, click here.
  • Laboratory Corporation of America Holdings LH and Covance CVD today announced that they have entered into a definitive agreement under which LabCorp will acquire Covance for cash and LabCorp shares currently valued at $105.12 per Covance share, or an equity value of approximately $6.1 billion and an enterprise value of approximately $5.6 billion. To read the full news, click here.
  • PDI PDII announced the acquisition of RedPath Integrated Pathology, a molecular diagnostics company helping physicians better manage patients at risk for certain types of gastrointestinal cancers through its proprietary PathFinderTG^® platform. To read the full news, click here.
Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
Posted In: NewsEurozoneFuturesGlobalPre-Market OutlookMarketsHealth CareHealth Care ServicesPacific CrestUS Stock Futures
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...